Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Unicycive Therapeutics, Inc. | Chief Financial Officer | Stock Options | 916K | Aug 12, 2024 | Direct | ||
Unicycive Therapeutics, Inc. | Chief Financial Officer | Stock Options | 875K | Apr 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
UNCY | Unicycive Therapeutics, Inc. | Aug 12, 2024 | 1 | $0 | 4 | Aug 14, 2024 | Chief Financial Officer |
UNCY | Unicycive Therapeutics, Inc. | Apr 15, 2024 | 1 | $0 | 4 | Apr 17, 2024 | Chief Financial Officer |
UNCY | Unicycive Therapeutics, Inc. | Aug 28, 2023 | 1 | $0 | 4 | Aug 30, 2023 | Chief Financial Officer |
UNCY | Unicycive Therapeutics, Inc. | Nov 21, 2022 | 1 | $0 | 4 | Nov 23, 2022 | Chief Financial Officer |
UNCY | Unicycive Therapeutics, Inc. | Jul 15, 2021 | 1 | $0 | 4 | Jul 26, 2021 | Chief Financial Officer |
UNCY | Unicycive Therapeutics, Inc. | Jul 12, 2021 | 0 | $0 | 3 | Jul 12, 2021 | Chief Financial Officer |